Karen C. Wolff

Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I

Tao Jiang, Kelli Kuhen, Karen C. Wolff et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 290 citations

Medicinal Chemistry, Biochemistry, Biological Evaluations +10

Mutations in an Auxin Receptor Homolog AFB5 and in SGT1b Confer Resistance to Synthetic Picolinate Auxins and Not to 2,4-Dichlorophenoxyacetic Acid or Indole-3-Acetic Acid in Arabidopsis

Terence A. Walsh, Roben Neal, Ann Owens Merlo et al. · PLANT PHYSIOLOGY · 2006 · 224 citations · Full text

Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2

Tao Jiang, Kelli Kuhen, Karen C. Wolff et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 197 citations

Medicinal Chemistry, Biochemistry, Biological Evaluations +11

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions

Malina A. Bakowski, Nathan Beutler, Karen C. Wolff et al. · Nature Communications · 2021 · 127 citations · Full text

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah et al. · Cell Reports · 2021 · 117 citations · Full text